Dolphin Pharmaceutical Limited - Company Profile

It is a pharma public limited company based in Surat, Gujarat, India, established in 2011.
2011 Surat, Gujarat, India Active
Last Updated:
Access Report
About Dolphin Pharmaceutical Limited

Dolphin Pharmaceutical Limited, a active public limited company, was established on 16 April 2011 in Surat, Gujarat, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24230GJ2011PLC064980. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹3.00 M.

It upholds a compliant status. Its leadership includes Dilipbhai Devchandbhai Zalawadiya (Director), Hareshkumar Babubhai Sorathiya (Director), Jaysukhbhai Devchandbhai Zalawadiya (Director). Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 155/156/157, New Sardar Market (A.P.M.C) Commercial Complex,Puna Kumbharia Road, Surat, Gujarat, 395010.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230GJ2011PLC064980

  • Registration Number

    064980

  • Incorporation Date

    16 April 2011

  • Authorized Capital

    ₹1.00 Cr

  • Paid-Up Capital

    ₹3.00 M

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 Cr
  • Paid Up Capital ₹ 3.00 M
  • Company Age 14 Year, 9 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** -100.00%
  • Profit Growth **** -111.00%
  • Ebitda **** -19.49%
  • Net Worth -49.66%
  • Total Assets -51.97%
Company report

Dolphin Pharmaceutical Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Dolphin Pharmaceutical Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Dolphin Pharmaceutical Limited?
Current Directors
Name Designation Appointment Date Status
Dilipbhai Devchandbhai Zalawadiya Director 16 Apr 2011 Current
Hareshkumar Babubhai Sorathiya Director 16 Apr 2011 Current
Jaysukhbhai Devchandbhai Zalawadiya Director 16 Apr 2011 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Dolphin Pharmaceutical.

Dolphin Pharmaceutical Limited, for the financial year ended 2024, experienced significant reduction in revenue, with a 100% decrease. The company also saw a substantial fall in profitability, with a 111% decrease in profit. The company's net worth observed a substantial decline by a decrease of 49.66%.

Dolphin Pharmaceutical revenue growth over time
Dolphin Pharmaceutical profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -100.00%
*******
*******
*******
*******
Revenue from Operations
*******
 -100.00%
*******
*******
*******
*******
Total Assets
*******
 -51.97%
*******
*******
*******
*******
Profit or Loss
*******
 -111.00%
*******
*******
*******
*******
Net Worth
*******
 -49.66%
*******
*******
*******
*******
EBITDA
*******
 -19.49%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Dolphin Pharmaceutical?

In 2024, Dolphin Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Dolphin Pharmaceutical?

Unlock and access historical data on people associated with Dolphin Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Dolphin Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dolphin Pharmaceutical's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Dolphin Pharmaceutical
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Dolphin Pharmaceutical Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Dolphin Pharmaceutical Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was recorded as a recent event.

  • Director Appointment

    The activity Dilipbhai Devchandbhai Zalawadiya was appointed as a Director was appointed as a Director on 16 Apr 2011 & has been associated with this company since 14 years 9 months . was completed.

  • Director Appointment

    Progress on Hareshkumar Babubhai Sorathiya was appointed as a Director was appointed as a Director on 16 Apr 2011 & has been associated with this company since 14 years 9 months . was documented.

  • Director Appointment

    Jaysukhbhai Devchandbhai Zalawadiya was appointed as a Director was appointed as a Director on 16 Apr 2011 & has been associated with this company since 14 years 9 months . was recorded as a recent event.

  • Company Incorporation

    Progress on Dolphin Pharmaceutical Limited was registered on 16 Apr 2011 with Roc Ahmedabad & aged 14 years 9 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Dolphin Pharmaceutical Limited?

The CIN of Dolphin Pharmaceutical Limited is U24230GJ2011PLC064980.

Where is Dolphin Pharmaceutical Limited headquartered?

Dolphin Pharmaceutical Limited is headquartered at 155/156/157, New Sardar Market (A.P.M.C) Commercial Complex,Puna Kumbharia Road, Surat, Gujarat, 395010.

When was Dolphin Pharmaceutical Limited incorporated?

Dolphin Pharmaceutical Limited was incorporated on 16 April 2011.

Who are the current directors of Dolphin Pharmaceutical Limited?

The current directors of Dolphin Pharmaceutical Limited are

What is the primary industry of Dolphin Pharmaceutical Limited?

The primary industry of Dolphin Pharmaceutical Limited is Trade.

Is Dolphin Pharmaceutical Limited a listed company?

Dolphin Pharmaceutical Limited is unlisted.

What is the capital structure of Dolphin Pharmaceutical Limited?

The authorized capital of Dolphin Pharmaceutical Limited is ₹1.00 Cr, and the paid-up capital is ₹3.00 M.

What is the compliance status of Dolphin Pharmaceutical Limited?

The compliance status of Dolphin Pharmaceutical Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available